Thus, analysis of the currently identified EDN1 polymorphism may be useful in the assessment of risk for OSA in a high risk population, such as those children who manifest snoring or have enlarged tonsils and adenoids. This evidence concerns the gene EDN1 and obstructive sleep apnea syndrome.